Epidemiology and demographics template: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
(insert disease state here) is a major health problem affecting _____ patients in the United States and ____ patients worldwide. | (insert disease state here) is a major health problem affecting _____ patients in the United States and ____ patients worldwide. | ||
or (insert disease state here) is a [[rare disease]]( | or | ||
(insert disease state here) is a [[rare disease]] (defined as a prevalence of < 50 per 100,000 patients or < 200,000 patients affected in the United States) with a prevalence of ______ per 100,000 patients. | |||
==Prevalence== | ==Prevalence== | ||
Revision as of 16:37, 19 July 2012
Template:(insert disease state here) Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
(insert disease state here) is a major health problem affecting _____ patients in the United States and ____ patients worldwide.
or
(insert disease state here) is a rare disease (defined as a prevalence of < 50 per 100,000 patients or < 200,000 patients affected in the United States) with a prevalence of ______ per 100,000 patients.
Prevalence
Worldwide, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
Worldwide, the prevalence of (insert disease state here) is _____ per 100,000 patients.
In developed countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
In developed countries, the prevalence of (insert disease state here) is _____ per 100,000 patients.
In developing countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
In developing countries, the prevalence of (insert disease state here) is _____ per 100,000 patients.
In Africa, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
In Africa, the prevalence of (insert disease state here) is _____ per 100,000 patients.
Incidence
Worldwide, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
Worldwide, the incidence of (insert disease state here) is _____ per 100,000 patients.
In developed countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
In developed countries, the incidence of (insert disease state here) is _____ per 100,000 patients.
In developing countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
In developing countries, the incidence of (insert disease state here) is _____ per 100,000 patients.
In Africa, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
In Africa, the incidence of (insert disease state here) is _____ per 100,000 patients.
Age
The prevalence of (insert disease state here) increases with age.
Gender
(insert disease state here) is more common in males females